Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00823433 · ClinicalTrials.gov registry record · Early Phase 1
Oral Penicillin and Penicillin Levels in Venous Umbilical Cord Blood
A Early Phase 1 study, sponsored by Corewell Health East.
- Terminated
- Registry status
- Early Phase 1
- Development phase
- 25
- Enrollment target
NCT00823433: Clinical Trial Early Phase 1 study, sponsored by Corewell Health East.
NCT00823433 is a Early Phase 1 study that was terminated before completion, run by Corewell Health East. The registered enrollment target is 25 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (53% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00823433, a Early Phase 1 study, was terminated before completion, sponsored by Corewell Health East.
- TERMINATED
- Registry status
- Early Phase 1
- Development phase
- 25 participants
- Enrollment target
Study Summary
Pregnant,laboring women will receive 2 grams of oral penicillin V before delivery. At the time of delivery of the infant, umbilical vein cord blood will be obtained from the umbilical cord. These cord blood samples will be sent for bioassay of penicillin levels.
Interventions
- DRUG oral penicillin V
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2009-01 |
| Est. Completion | 2009-12 |
| Phase | Early Phase 1 |
Why NCT00823433 stopped before completion
NCT00823433 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (53% lower).
The record links to 0 conditions, and to 1 intervention - of which oral penicillin V is the first listed.
NCT00823433 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00823433 about?
NCT00823433 is a clinical study titled "Oral Penicillin and Penicillin Levels in Venous Umbilical Cord Blood". Pregnant,laboring women will receive 2 grams of oral penicillin V before delivery. At the time of delivery of the infant, umbilical vein cord blood will be obtained from the umbilical cord. These cord blood samples will be sent for bioassay of penicillin levels.
What is the current status of trial NCT00823433?
This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 25 participants. The study started on 2009-01. Estimated completion is 2009-12.
What interventions are being tested in trial NCT00823433?
The interventions under investigation include: oral penicillin V (DRUG).
Who is sponsoring clinical trial NCT00823433?
This trial is sponsored by Corewell Health East, which has 106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00823433's enrollment target sits among peer trials
25 1000th of 2000 higher than 964 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia